AI assistant
Sending…
LEMAITRE VASCULAR INC — Director's Dealing 2018
Jul 19, 2018
31708_dirs_2018-07-19_3068495f-8c7b-4341-b2d3-4870799055fa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2018-07-18
Reporting Person: O'Connor John James (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-07-18 | Common Stock | M | 7500 | $6.67 | Acquired | 80210 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-07-18 | Stock Option (Right to Buy) | $6.67 | M | 7500 | Disposed | 2018-07-24 | Common Stock (7500) | Direct |
Footnotes
F1: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2: This option is fully vested and exercisable.
More from LEMAITRE VASCULAR INC
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 14
Regulatory Filings
2026
Apr 14
Annual Report
2026
Apr 14
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3